Heparan Sulphate HS8 Mediates FGF2 for Stem Cell Expansion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current strategies for expanding human mesenchymal stem cells (hMSCs) for therapeutic purposes face challenges such as low cell numbers and loss of multipotency during ex vivo expansion, leading to reduced quality and function of the cells for transplantation.
Innovation Solution
A novel heparan sulphate preparation, HS8, is identified that binds FGF2, enhancing stem cell proliferation while maintaining pluripotency, which is used in isolation or as a composition with FGF2 to stimulate stem cell growth and enrich for colony-forming units.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Quantity of substance
If current ex vivo expansion strategies (EGM substrates and FGF2) are used to increase stem cell numbers, then cell counts are improved, but multipotency is lost and cell quality deteriorates
Solution Approach 1:
The patent introduces HS8 as an intermediary substance that mediates between FGF2 and stem cells. HS8 binds to FGF2 with high affinity, forming a complex that selectively interacts with stem cell receptors. This intermediary role allows FGF2 signaling to be transmitted more effectively while filtering out off-target effects that cause differentiation, thus resolving the contradiction between cell proliferation and multipotency maintenance
Solution Approach 2:
The patent changes the chemical parameters of the expansion system by introducing HS8, a specific heparan sulfate structure with defined disaccharide composition and sulfation patterns. This parameter change in the molecular structure of the expanding agent enables selective enhancement of stem cell proliferation while preserving multipotency, overcoming the limitations of conventional FGF2 alone
2Productivity
If conventional expansion methods are used, then cell proliferation is achieved, but differentiated progenitors increase and cell function is reduced
Solution Approach 1:
HS8 acts as a selective mediator that enhances FGF2 signaling specifically in stem cells while blocking differentiation pathways. The unique structural features of HS8 enable it to form stable complexes with FGF2 that preferentially bind to stem cell receptors, thereby promoting proliferation without triggering differentiation programs, thus maintaining cell function quality
Solution Approach 2:
The patent uses HS8 to partially enhance FGF2 activity by providing selective structural support and stabilization. Rather than using excessive FGF2 concentrations that cause differentiation, the HS8-FGF2 complex achieves optimal signaling at lower concentrations, promoting proliferation while avoiding the harmful excessive stimulation that leads to differentiation
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
HS8 effectively increases the number of stem cells and maintains their multipotent characteristics, allowing for the expansion of stem cell cultures with a high proportion of pluripotent cells, addressing the limitations of existing expansion strategies.
Implementation Method 1
HS8 has been found to bind FGF2 and enhance the proliferation of stem cells whilst maintaining their pluripotency/multipotency
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A novel class of structurally and functionally related isolated Heparan sulphate is disclosed. The novel class of Heparan sulphates has been found to bind FGF2 and enhance the proliferation of stem cells whilst maintaining their pluripotency/multipotency.